Citation Impact
Citing Papers
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
2013
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Heparan Sulfate Glycosaminoglycans Are Receptors Sufficient To Mediate the Initial Binding of Adenovirus Types 2 and 5
2001
Sialic Acid Associated with αvβ3 Integrin Mediates HIV-1 Tat Protein Interaction and Endothelial Cell Proangiogenic Activation
2012
Interaction of Heparan Sulfate from Mammary Cells with Acidic Fibroblast Growth Factor (FGF) and Basic FGF
1998
Parenteral Anticoagulants
2008
Biosynthesis of Heparin/Heparan Sulfate
1997
Parenteral Anticoagulants
2012 Standout
Heparin-Protein Interactions
2002 Standout
Structure and Biological Activity of Heparin
1985
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Structural basis for fibroblast growth factor receptor activation
2005
Molecular characterization and organization of porin from Rhodobacter capsulatus strain 37B4
1996
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
2005
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Imaging the Glycosylation State of Cell Surface Glycoproteins by Two‐Photon Fluorescence Lifetime Imaging Microscopy
2013 StandoutNobel
Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeutics
2009
Survey of the year 2004 commercial optical biosensor literature
2005
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Isolation and characterization of heparan sulfate from crude porcine intestinal mucosal peptidoglycan heparin
1995
Tau in physiology and pathology
2015 Standout
Cell surface adherence and endocytosis of protein transduction domains
2003
Cell penetration properties of maurocalcine, a natural venom peptide active on the intracellular ryanodine receptor
2006
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Antithrombotic Therapy for VTE Disease
2012 Standout
Sulfotransferases: Structure, Mechanism, Biological Activity, Inhibition, and Synthetic Utility
2004
A Conserved Mechanism for Sulfonucleotide Reduction
2005 StandoutNobel
Purification of Heparan Sulfate D-Glucosaminyl 3-O-Sulfotransferase
1996
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Heparin and Low-Molecular-Weight Heparin
2004
Lysine-Heparin Interactions in Antithrombin. Properties of K125M and K290M,K294M,K297M Variants
1994
A Cell-Penetrating Scorpion Toxin Enables Mode-Specific Modulation of TRPA1 and Pain
2019 StandoutNobel
Pharmacodynamics, Clinical Indications, and Adverse Effects of Heparin
1992
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III
1987
The 2.6 Å structure of antithrombin indicates a conformational change at the heparin binding site 1 1Edited by R. Huber
1997
Mycobacterium tuberculosis Rv3406 Is a Type II Alkyl Sulfatase Capable of Sulfate Scavenging
2013 StandoutNobel
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Evaluation of the Activated Partial Thrombo-plastin Time (APTT) Sensitivity to Heparin Using Five Commercial Reagents: Implications for Therapeutic Monitoring
1998
Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides
2005
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Survey of the year 2003 commercial optical biosensor literature
2004
Interaction of heparin and antithrombin III
1988
Substrate Specificity of Heparanases from Human Hepatoma and Platelets
1998
Complexes of Plasmid DNA with Basic Domain 47-57 of the HIV-1 Tat Protein Are Transferred to Mammalian Cells by Endocytosis-mediated Pathways
2003
A model of the platelet factor 4 complex with heparin
1992
Synthesis and Microcontact Printing of Dual End‐Functionalized Mucin‐like Glycopolymers for Microarray Applications
2009 StandoutNobel
Heparin
1991
Delivery of bioactive molecules into the cell: the Trojan horse approach
2004
Survey of the year 2005 commercial optical biosensor literature
2006
Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer
2004
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Organic Azides: An Exploding Diversity of a Unique Class of Compounds
2005 Standout
Cellulose: Fascinating Biopolymer and Sustainable Raw Material
2005 Standout
Crystal Structure of a Ternary FGF-FGFR-Heparin Complex Reveals a Dual Role for Heparin in FGFR Binding and Dimerization
2000
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Anemia of Chronic Disease
2005 Standout
Cell Signaling by Receptor Tyrosine Kinases
2000 Standout
Glycosaminoglycans and the regulation of blood coagulation
1993
A 96-well dot-blot assay for carbohydrate sulfotransferases
2002 StandoutNobel
Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity
1983
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells
2003 StandoutNobel
Serpin Structure, Mechanism, and Function
2002 Standout
Density Variant Glycan Microarray for Evaluating Cross-Linking of Mucin-like Glycoconjugates by Lectins
2012 StandoutNobel
STRUCTURAL STUDIES ON A BIOLOGICALLY ACTIVE HEXASACCHARIDE OBTAINED FROM HEPARIN
1981
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
2003 Standout
Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo
2010
Regioselectively Modified Cellulose and Chitosan Derivatives for Mono- and Multilayer Surface Coatings of Hemocompatible Biomaterials
2003
Biosynthesis of heparin
1986
Binding and endocytosis of heparin by human endothelial cells in culture
1985
Nonviral Vectors for Gene Delivery
2008 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Signaling Mechanisms of HIV-1 Tat-Induced Alterations of Claudin-5 Expression in Brain Endothelial Cells
2005
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.
1994
A Glycopolymer Chaperone for Fibroblast Growth Factor-2
2004
Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits
1982
Further characterization of the antithrombin-binding sequence in heparin
1982 Standout
Activation of heparin cofactor II by dermatan sulfate.
1983
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
The antithrombin-binding sequence of heparin studied by n.m.r. spectroscopy
1981
Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: A co-operative study
1985
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics
1993
Recent Developments in Peptide-Based Nucleic Acid Delivery
2008
Infection of Human Dendritic Cells by Dengue Virus Causes Cell Maturation and Cytokine Production
2001
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?
2019
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Low-Molecular-Weight Heparins
1997 Standout
Die charakteristische AT‐III‐Bindungsregion in Heparin: eine Leitstruktur für neue synthetische Antithrombotica
1993
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Kinetics of factor Xa inhibition by tissue factor pathway inhibitor.
1993
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Multiple functional domains of the heparin molecule.
1981
Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin
1989
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4
1984
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Single-Molecule Motions of Oligoarginine Transporter Conjugates on the Plasma Membrane of Chinese Hamster Ovary Cells
2008 StandoutNobel
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Extension and structural variability of the antithrombin-binding sequence in heparin.
1984
Fluorescence-Based Blood Coagulation Assay Device for Measuring Activated Partial Thromboplastin Time
2010 StandoutNobel
Mono- and bidimensional 500 MHz 1H-NMR spectra of a synthetic pentasaccharide corresponding to the binding sequence of heparin to antithrombin-III: Evidence for conformational peculiarity of the sulfated iduronate residue
1985
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic
2020
Evaluation of critical groups required for the binding of heparin to antithrombin.
1984
Works of Pasqua Oreste being referenced
Correlation between structure, fat-clearing and anticoagulant properties of heparins and heparan sulphates.
1983
Distinct Role of 2-O-, N-, and 6-O-Sulfate Groups of Heparin in the Formation of the Ternary Complex with Basic Fibroblast Growth Factor and Soluble FGF Receptor-1
1994
Interaction of HIV-1 Tat Protein with Heparin
1997
Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans
1993
Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues
2016
Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor
1994
Biotechnological Engineering of Heparin/Heparan Sulphate: A Novel Area of Multi-Target Drug Discovery
2005
Sulfated Escherichia coli K5 Polysaccharide Derivatives Inhibit Dengue Virus Infection of Human Microvascular Endothelial Cells by Interacting with the Viral Envelope Protein E Domain III
2013
Micromethod for the Determination of Heparin in Plasma after Intravenous and Subcutaneous Administration
1993
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV‐1 Tat protein antagonists
2004
Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides
2009
Multiple Interactions of HIV-I Tat Protein with Size-defined Heparin Oligosaccharides
1999
Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5
1994
Antiangiogenic Activity of Semisynthetic Biotechnological Heparins
2004
The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence Chemical and13C nuclear-magnetic-resonance studies
1981
Bleeding Effects Associated with Heparin Contaminants
1989
Highly Sulfated K5 Escherichia coli Polysaccharide Derivatives Inhibit Respiratory Syncytial Virus Infectivity in Cell Lines and Human Tracheal-Bronchial Histocultures
2014
Sulfated K5 Escherichia coli polysaccharide derivatives inhibit human immunodeficiency type-1 (HIV-1) infection: candidate microbicides to prevent sexual HIV transmission.
2004
Inhibition of Herpes Simplex Virus Types 1 and 2 In Vitro Infection by Sulfated Derivatives of Escherichia coli K5 Polysaccharide
2008
Anti-Xa active heparin oligosaccharides
1980
Fingerprinting of heparins by low-amperage electrophoresis in barium acetate
1980
Sulfated K5 Escherichia coli Polysaccharide Derivatives as Wide-Range Inhibitors of Genital Types of Human Papillomavirus
2008
Sulfated Derivatives of Escherichia coli K5 Capsular Polysaccharide Are Potent Inhibitors of Human Cytomegalovirus
2010